Provident Financial Services, Inc. Schedules First Quarter Earnings Conference Call
11 avr. 2024 09h00 HE
|
Provident Financial Services, Inc.
ISELIN, N.J., April 11, 2024 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE: PFS) announced that it expects to release financial results for the quarter ended March 31, 2024 on...
Triumph Financial Announces Schedule for First Quarter 2024 Earnings Release and Conference Call
05 avr. 2024 16h07 HE
|
Triumph Financial, Inc.
DALLAS, April 05, 2024 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (Nasdaq: TFIN) today announced that it expects to release its first quarter financial results and management commentary after the...
Optinose to Present at the Needham Virtual Healthcare Conference
04 avr. 2024 16h01 HE
|
Optinose, Inc.
YARDLEY, Pa., April 04, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024
04 avr. 2024 08h45 HE
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, April 04, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA...
Eagle Bancorp Announces Earnings Call on April 25, 2024
03 avr. 2024 06h00 HE
|
Eagle Bancorp, Inc.
BETHESDA, Md., April 03, 2024 (GLOBE NEWSWIRE) -- Eagle Bancorp, Inc., (the “Company”) (NASDAQ: EGBN), the parent company of EagleBank, today announced that it will host a teleconference call for...
Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results
01 avr. 2024 16h01 HE
|
Yield10 Bioscience, Inc.
-Granted global commercial license to Vision Bioenergy for Camelina addressing the biofuel market-Advanced regulatory and seed scale-up program for omega-3 Camelina-E3902 oil trait in Camelina cleared...
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024
28 mars 2024 16h01 HE
|
Yield10 Bioscience, Inc.
WOBURN, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will...
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
19 mars 2024 16h05 HE
|
Cyclacel
– On Track to Start Oral Fadraciclib Phase 2 Proof of Concept in 1H 2024 – – Expect to Report Final Data from Fadraciclib 065-101 Dose Escalation – – Oral Plogosertib Preclinical Data Support...
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
14 mars 2024 16h39 HE
|
CytoSorbents
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results
13 mars 2024 16h05 HE
|
Cyclacel
BERKELEY HEIGHTS, N.J., March 13, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing...